Literature DB >> 31031392

Primary membranous nephropathy with concomitant IgA nephropathy.

Reza Khorsan1, Ramy M Hanna1, Khalid Ameen1, Farid Arman1, Niloofar Nobakht1, Huma Hasnain1, Ashley Hyunh1, Anjay Rastogi1.   

Abstract

Membranous nephropathy (MN), an autoimmune glomerulonephritis which can occur in primary and secondary forms, is one of the most common inflammatory glomerulopathies in elderly patients. The pathophysiology of the primary form is generally due to circulating immunoglobulin (IgG4) antibodies which often target phospholipase A2 receptors (anti-PLA2R) and Thrombospondin Type 1 Domain containing 7A (anti THSD7A). IgA nephropathy is one of the most common autoimmune glomerular diseases in the world and presents with a spectrum of disease ranging from asymptomatic mild hematuria and proteinuria to rapidly progressive crescentic glomerulonephritis. We present a rare case of concomitant IgA and primary MN in a single patient treated successfully with renin-angiotensin-aldosterone blockade, corticosteroids, and calcineurin inhibitors. The peak proteinuria was near 7.5-8 g protein/g creatinine by various measures. Serum creatinine remained normal, and anti-PLA2R was detectable and decreased with successful treatment. Clinicians should be aware of the possibility of two glomerular disorders in patients with glomerulonephritis and atypical presentations for any single disorder.

Entities:  

Year:  2019        PMID: 31031392     DOI: 10.4103/1319-2442.256863

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  2 in total

1.  Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.

Authors:  Feng Ping Ji; Lu Wen; Yan Ping Zhang; Er Peng Liu; Jian Guo Wen
Journal:  Int Urol Nephrol       Date:  2021-09-28       Impact factor: 2.370

2.  Case Report: Coexistence of Anti-Glomerular Basement Membrane Disease, Membranous Nephropathy, and IgA Nephropathy in a Female PatientWith Preserved Renal Function.

Authors:  Wei Qu; Nan Liu; Tianhua Xu; Binyao Tian; Meng Wang; Yanqiu Li; Jianfei Ma; Li Yao
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.